Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$381,546
-$81,162 QoQ
Shares Held
3,020
-9.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,525
of 2,266 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAGNOLIA CAPITAL ADVISORS LLC holds $19,446,017 across 8 Drug Manufacturers - General names. GILD ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,906 | $5,884,404 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,718 | $4,461,263 | |
| 3 | ABBV |
AbbVie Inc.
|
16,722 | $4,207,924 | |
| 4 | JNJ |
Johnson & Johnson
|
11,815 | $3,000,655 | |
| 5 | AMGN |
Amgen Inc
|
2,427 | $878,865 | |
| 6 | PFE |
Pfizer Inc
|
16,265 | $391,661 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,020 | $381,546 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,160 | $239,699 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $381,546 | 3,020 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $462,708 | 3,320 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $403,323 | 3,286 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $343,656 | 3,096 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $340,038 | 3,067 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $339,959 | 3,034 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $300,849 | 3,257 | Shares | Sole | 2025-05-13 | |
| 2022-03-31 | $206,945 | 3,481 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $235,256 | 3,240 | Shares | Sole | 2022-01-26 | |
| No filing history on record for this holder in this stock. | ||||||